Polygonati Rhizoma Prevents Glucocorticoid‐Induced Growth Inhibition of Muscle via Promoting Muscle Angiogenesis Through Deoxycholic Acid
Journal of Cachexia, Sarcopenia and Muscle · 2025-06 · 16 (3)
DOI: 10.1002/jcsm.13853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 16.06.2025. Verfasst von Shiyi Shi und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, China. Hauptthemen laut MEDLINE: Muscle, Skeletal, Glucocorticoids, Polygonatum, Plant Extracts. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Hubei Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Glucocorticoids are commonly used in clinical treatments but can cause muscle growth inhibition and weakness at high doses. The mechanisms and treatments for glucocorticoid‐induced muscle growth inhibition remain poorly understood. This study aims to investigate the anti‐atrophic effects of Polygonati Rhizoma (PR) and a mixture of low‐dose fructose and glucose (MFG, an active component mimic in PR) on skeletal muscle.
Methods
Male C57BL/6 mice (3‐week‐old, n = 8) were gavaged with aqueous extract of PR (AEPR). MFG was used to gavage normal male C57BL/6 mice (3‐week‐old, n = 10) and male C57BL/6 mice with dexamethasone (DEX)‐induced muscle growth inhibition (3‐week‐old, n = 7). After 2 weeks of gavage, the body weight and muscle mass of the mice were measured. Intestinal content was collected, the concentration of deoxycholic acid (DCA) was analysed and gut microbiota changes were assessed through 16S rRNA gene sequencing. Muscle angiogenesis was examined through the expression of vascular endothelial growth factors (VEGFs), focusing on the DCA‐activated TGR5/cAMP/PKA/pCREB pathway.
Results
AEPR significantly increased the body weight (22.90 ± 0.90 vs. 21.83 ± 0.87 g, * p < 0.05) and grip strength (1.32 ± 0.11 vs. 1.04 ± 0.12 N, *** p < 0.001) of mice. MFG (0.5 g/kg body weight) also significantly elevated the body weight (21.44 ± 0.71 vs. 20.14 ± 0.82 g, ** p < 0.01) and muscle mass (0.37 ± 0.018 vs. 0.33 ± 0.035 g, ** p < 0.01) of mice. In the DEX group, MFG restored the DCA level (log 2 [intensity]) in intestinal content (25.41 ± 1.64 vs. 22.69 ± 0.74, * p < 0.05) and increased the abundance of Collinsella aerofaciens as measured by DNA concentration (0.80 ± 0.64 vs. 0.24 ± 0.09 pg/μL, p = 0.096). Mechanistically, MFG upregulated VEGFs expression and promoted muscle angiogenesis via the TGR5/cAMP/PKA/pCREB pathway.
Conclusions
This study demonstrates that AEPR and its active component mimic MFG can promote muscle growth and MFG mitigates muscle growth inhibition by modulating gut microbiota and enhancing muscle angiogenesis. These findings suggest that fructose‐containing treatments are novel strategies to address skeletal muscle dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, China.
- Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, China.
- Institute of Animal Husbandry and Veterinary Sciences, Wuhan Academy of Agricultural Sciences, Wuhan, China.
- Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, China.
- Cambridge-Suda Genomic Resource Center, Suzhou Medical College, Soochow University, Suzhou, China.
- College of Plant Science and Technology, Huazhong Agricultural University, Wuhan, China.
ORCID-Profile: Tongxing Song
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Hubei Provincial Natural Science Foundation of China
- Key Research and Development Plan Project of Jiangxi Province
- Jiangxi Province Key Laboratory of Animal Green and Healthy Breeding
- Knowledge Innovation Program of Wuhan-Shuguang Project
- Fundamental Research Funds for the Central Universities
- National Innovation and Entrepreneurship Training Program for Undergraduate
Zitieren
APA
Shi, S., Li, R., Han, Y., Xie, J., Wang, S., Liu, J., Wan, F., Hou, G., Liu, Z., Sun, X., Zuo, B., Jia, Z., Mei, Z., & Song, T. (2025). Polygonati Rhizoma Prevents Glucocorticoid‐Induced Growth Inhibition of Muscle via Promoting Muscle Angiogenesis Through Deoxycholic Acid. Journal of Cachexia, Sarcopenia and Muscle, 16(3). https://doi.org/10.1002/jcsm.13853
Vancouver
Shi S, Li R, Han Y, Xie J, Wang S, Liu J, et al. Polygonati Rhizoma Prevents Glucocorticoid‐Induced Growth Inhibition of Muscle via Promoting Muscle Angiogenesis Through Deoxycholic Acid. Journal of Cachexia, Sarcopenia and Muscle. 2025;16(3). doi:10.1002/jcsm.13853
BibTeX
@article{Shi2025,
author = {Shi, Shiyi and Li, Rui and Han, Yanxu and Xie, Jiahao and Wang, Shaoshuai and Liu, Jie and Wan, Fangyan and Hou, Gaifeng and Liu, Zuhong and Sun, Xiaobo and Zuo, Bo and Jia, Zhihao and Mei, Zhinan and Song, Tongxing},
title = {Polygonati Rhizoma Prevents Glucocorticoid‐Induced Growth Inhibition of Muscle via Promoting Muscle Angiogenesis Through Deoxycholic Acid},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2025},
volume = {16},
number = {3},
doi = {10.1002/jcsm.13853}
}
EUVIMED